1144 related articles for article (PubMed ID: 27576775)
21. Frequency, Predictors, and Impact of Combined Antiplatelet Therapy on Venous Thromboembolism in Patients With Symptomatic Atherosclerosis.
Cavallari I; Morrow DA; Creager MA; Olin J; Bhatt DL; Steg PG; Storey RF; Cohen M; Scirica BS; Piazza G; Goodrich EL; Braunwald E; Sabatine MS; Bonaca MP
Circulation; 2018 Feb; 137(7):684-692. PubMed ID: 29084737
[TBL] [Abstract][Full Text] [Related]
22. Ticagrelor: A Review in Long Term Secondary Prevention of Cardiovascular Events.
Al-Salama ZT; Keating GM; Keam SJ
Drugs; 2017 Dec; 77(18):2025-2036. PubMed ID: 29150806
[TBL] [Abstract][Full Text] [Related]
23. Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long-Term Ticagrelor in Stable Patients With Prior Myocardial Infarction.
Magnani G; Ardissino D; Im K; Budaj A; Storey RF; Steg PG; Bhatt DL; Cohen M; Oude Ophius T; Goudev A; Parkhomenko A; Kamensky G; Angiolillo DJ; López-Sendón J; Johanson P; Braunwald E; Sabatine MS; Bonaca MP
J Am Heart Assoc; 2021 Feb; 10(4):e017008. PubMed ID: 33559485
[TBL] [Abstract][Full Text] [Related]
24. Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS-TIMI 54 Trial.
Furtado RHM; Venkateswaran RV; Nicolau JC; Gurmu Y; Bhatt DL; Storey RF; Steg PG; Magnani G; Goto S; Dellborg M; Kamensky G; Isaza D; Aylward P; Johanson P; Bonaca MP
J Am Heart Assoc; 2020 May; 9(10):e015785. PubMed ID: 32410485
[TBL] [Abstract][Full Text] [Related]
25. Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA.
Johnston SC; Amarenco P; Denison H; Evans SR; Himmelmann A; James S; Knutsson M; Ladenvall P; Molina CA; Wang Y;
N Engl J Med; 2020 Jul; 383(3):207-217. PubMed ID: 32668111
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in relation to renal function: insights from the PEGASUS-TIMI 54 trial.
Magnani G; Storey RF; Steg G; Bhatt DL; Cohen M; Kuder J; Im K; Aylward P; Ardissino D; Isaza D; Parkhomenko A; Goudev AR; Dellborg M; Kontny F; Corbalan R; Medina F; Jensen EC; Held P; Braunwald E; Sabatine MS; Bonaca MP
Eur Heart J; 2016 Jan; 37(4):400-8. PubMed ID: 26443023
[TBL] [Abstract][Full Text] [Related]
27. Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial.
Storey RF; Angiolillo DJ; Bonaca MP; Thomas MR; Judge HM; Rollini F; Franchi F; Ahsan AJ; Bhatt DL; Kuder JF; Steg PG; Cohen M; Muthusamy R; Braunwald E; Sabatine MS
J Am Coll Cardiol; 2016 Mar; 67(10):1145-1154. PubMed ID: 26965534
[TBL] [Abstract][Full Text] [Related]
28. Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS-TIMI 54.
Bonaca MP; Wiviott SD; Morrow DA; Steg PG; Hamm C; Bhatt DL; Storey RF; Cohen M; Kuder J; Im K; Magnani G; Budaj A; Nicolau JC; Parkhomenko A; López-Sendón J; Dellborg M; Diaz R; Van de Werf F; Corbalán R; Goudev A; Jensen EC; Johanson P; Braunwald E; Sabatine MS
J Am Heart Assoc; 2018 Nov; 7(22):e009260. PubMed ID: 30571502
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and Safety of Ticagrelor in Relation to Aspirin Use Within the Week Before Randomization in the SOCRATES Trial.
Wong KSL; Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Himmelmann A; Kasner SE; Knutsson M; Ladenvall P; Minematsu K; Molina CA; Wang Y; Johnston SC;
Stroke; 2018 Jul; 49(7):1678-1685. PubMed ID: 29915123
[TBL] [Abstract][Full Text] [Related]
30. A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An Investigator-Initiated trial.
de Waha A; Sandner S; von Scheidt M; Boening A; Koch-Buettner K; Hammel D; Hambrecht R; Danner BC; Schöndube FA; Goerlach G; Fischlein T; Schmoeckel M; Oberhoffer M; Schulz R; Walther T; Ziegelhöffer T; Knosalla C; Schönrath F; Beyersdorf F; Siepe M; Attmann T; Misfeld M; Mohr FW; Sievers HH; Joost A; Putman LM; Laufer G; Hamm C; Zeymer U; Kastrati A; Radke PW; Lange R; Cremer J; Schunkert H
Am Heart J; 2016 Sep; 179():69-76. PubMed ID: 27595681
[TBL] [Abstract][Full Text] [Related]
31. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial.
Vranckx P; Valgimigli M; Jüni P; Hamm C; Steg PG; Heg D; van Es GA; McFadden EP; Onuma Y; van Meijeren C; Chichareon P; Benit E; Möllmann H; Janssens L; Ferrario M; Moschovitis A; Zurakowski A; Dominici M; Van Geuns RJ; Huber K; Slagboom T; Serruys PW; Windecker S;
Lancet; 2018 Sep; 392(10151):940-949. PubMed ID: 30166073
[TBL] [Abstract][Full Text] [Related]
32. Characteristics and outcomes in patients with a prior myocardial infarction treated with extended dual antiplatelet therapy with ticagrelor 60 mg: findings from ALETHEIA, a multi-country observational study.
Bonaca MP; Lesén E; Giannitsis E; Hedberg J; Jernberg T; Lambrelli D; Duong M; Maggioni AP; Ariza-Solé A; Ten Berg J; Storey RF
Eur Heart J Cardiovasc Pharmacother; 2023 Dec; 9(8):701-708. PubMed ID: 37653447
[TBL] [Abstract][Full Text] [Related]
33. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.
Bhatt DL; Steg PG; Mehta SR; Leiter LA; Simon T; Fox K; Held C; Andersson M; Himmelmann A; Ridderstråle W; Chen J; Song Y; Diaz R; Goto S; James SK; Ray KK; Parkhomenko AN; Kosiborod MN; McGuire DK; Harrington RA;
Lancet; 2019 Sep; 394(10204):1169-1180. PubMed ID: 31484629
[TBL] [Abstract][Full Text] [Related]
34. Prolonged dual antiplatelet therapy in stable coronary disease: comparative observational study of benefits and harms in unselected versus trial populations.
Timmis A; Rapsomaniki E; Chung SC; Pujades-Rodriguez M; Moayyeri A; Stogiannis D; Shah AD; Pasea L; Denaxas S; Emmas C; Hemingway H
BMJ; 2016 Jun; 353():i3163. PubMed ID: 27334486
[TBL] [Abstract][Full Text] [Related]
35. Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: insights from the PLATelet inhibition and patient outcomes (PLATO) trial.
Brilakis ES; Held C; Meier B; Cools F; Claeys MJ; Cornel JH; Aylward P; Lewis BS; Weaver D; Brandrup-Wognsen G; Stevens SR; Himmelmann A; Wallentin L; James SK
Am Heart J; 2013 Sep; 166(3):474-80. PubMed ID: 24016496
[TBL] [Abstract][Full Text] [Related]
36. Long-term use of ticagrelor in patients with prior heart attack: ticagrelor plus aspirin versus aspirin monotherapy.
Amico F; Schlesinger A; Mazzoni J
Postgrad Med; 2016; 128(2):164-9. PubMed ID: 26689345
[TBL] [Abstract][Full Text] [Related]
37. Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: a systematic review and meta-analysis.
Gouya G; Arrich J; Wolzt M; Huber K; Verheugt FW; Gurbel PA; Pirker-Kees A; Siller-Matula JM
Stroke; 2014 Feb; 45(2):492-503. PubMed ID: 24368560
[TBL] [Abstract][Full Text] [Related]
38. Risk stratification for secondary prevention with ticagrelor and aspirin: A closer look to patient subsets from the PEGASUS-TIMI 54 trial.
Capodanno D; Capranzano P; Buccheri S; Tamburino C
Int J Cardiol; 2015 Dec; 201():276-8. PubMed ID: 26301657
[No Abstract] [Full Text] [Related]
39. Elderly patients with acute coronary syndromes managed without revascularization: insights into the safety of long-term dual antiplatelet therapy with reduced-dose prasugrel versus standard-dose clopidogrel.
Roe MT; Goodman SG; Ohman EM; Stevens SR; Hochman JS; Gottlieb S; Martinez F; Dalby AJ; Boden WE; White HD; Prabhakaran D; Winters KJ; Aylward PE; Bassand JP; McGuire DK; Ardissino D; Fox KA; Armstrong PW
Circulation; 2013 Aug; 128(8):823-33. PubMed ID: 23852610
[TBL] [Abstract][Full Text] [Related]
40. Ticagrelor in Acute Stroke or Transient Ischemic Attack in Asian Patients: From the SOCRATES Trial (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes).
Wang Y; Minematsu K; Wong KS; Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Jonasson J; Molina CA; Johnston SC;
Stroke; 2017 Jan; 48(1):167-173. PubMed ID: 27899747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
